Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2026(Status and Outlook)
23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.Market Drivers:The 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) market is driven by the increasing prevalence of pneumococcal infections, particularly among high-risk populations such as the elderly, children, and immunocompromised individuals. Governments and health organizations worldwide are promoting vaccination programs to reduce the burden of pneumococcal diseases, which has significantly boosted market growth. Additionally, rising awareness about the importance of preventive healthcare and advancements in vaccine manufacturing technologies contribute to the increased adoption of PPSV23 vaccines.Market Challenges:However, the market faces challenges such as the high cost of vaccination, which limits accessibility in low- and middle-income countries. Moreover, the competition from newer pneumococcal conjugate vaccines (PCVs), which offer broader coverage and are preferred for pediatric use, poses a threat to PPSV23's market share. Another concern is vaccine hesitancy and misinformation, which can hinder immunization efforts and impact the overall market growth.Merck is the largest manufacturers of 23-Valent pneumococcal polysaccharide vaccine in the world, has a share about 78%. Other players include Sinovac, Kangtai Bio, CDIBP, Walvax, etc. United States is dominating the global 23-Valent pneumococcal polysaccharide vaccine market, has a share nearly 78% in terms of production. The largest market is United States, holds a share about 48%, followed by China and Europe, with around 25% and 22% market share respectively.
The global 23-Valent Pneumococcal Polysaccharide Vaccine market size was estimated at USD 1211.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global 23-Valent Pneumococcal Polysaccharide Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the 23-Valent Pneumococcal Polysaccharide Vaccine market.
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Sinovac
Kangtai Bio
CDIBP
Walvax
Market Segmentation (by Type)
Single Dose Vial
Pre-filled Syringe
Market Segmentation (by Application)
For Children (Over 2 Years Old)
For Adult
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the 23-Valent Pneumococcal Polysaccharide Vaccine Market
Overview of the regional outlook of the 23-Valent Pneumococcal Polysaccharide Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the 23-Valent Pneumococcal Polysaccharide Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of 23-Valent Pneumococcal Polysaccharide Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global 23-Valent Pneumococcal Polysaccharide Vaccine market size was estimated at USD 1211.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global 23-Valent Pneumococcal Polysaccharide Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the 23-Valent Pneumococcal Polysaccharide Vaccine market.
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Sinovac
Kangtai Bio
CDIBP
Walvax
Market Segmentation (by Type)
Single Dose Vial
Pre-filled Syringe
Market Segmentation (by Application)
For Children (Over 2 Years Old)
For Adult
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the 23-Valent Pneumococcal Polysaccharide Vaccine Market
Overview of the regional outlook of the 23-Valent Pneumococcal Polysaccharide Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the 23-Valent Pneumococcal Polysaccharide Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of 23-Valent Pneumococcal Polysaccharide Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 Key Market Segments
1.2.1 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
1.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Product Life Cycle
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2020-2025)
3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
3.8.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to 23-Valent Pneumococcal Polysaccharide Vaccine Market
5.7 ESG Ratings of Leading Companies
6 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
6.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type (2020-2025)
6.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2020-2025)
7 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Sales by Application (2020-2025)
7.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
8 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET SALES BY REGION
8.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
8.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
8.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region
8.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
8.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
8.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
8.3 North America
8.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
8.3.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
8.4.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
8.5.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
8.6.2 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
8.7.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of 23-Valent Pneumococcal Polysaccharide Vaccine by Region(2020-2025)
9.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production
9.4.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.4.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production
9.5.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production (2020-2025)
9.6.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China 23-Valent Pneumococcal Polysaccharide Vaccine Production (2020-2025)
9.7.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.7.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
10.1.3 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Sinovac
10.2.1 Sinovac Basic Information
10.2.2 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
10.2.3 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Market Performance
10.2.4 Sinovac Business Overview
10.2.5 Sinovac SWOT Analysis
10.2.6 Sinovac Recent Developments
10.3 Kangtai Bio
10.3.1 Kangtai Bio Basic Information
10.3.2 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
10.3.3 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Market Performance
10.3.4 Kangtai Bio Business Overview
10.3.5 Kangtai Bio SWOT Analysis
10.3.6 Kangtai Bio Recent Developments
10.4 CDIBP
10.4.1 CDIBP Basic Information
10.4.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
10.4.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Market Performance
10.4.4 CDIBP Business Overview
10.4.5 CDIBP Recent Developments
10.5 Walvax
10.5.1 Walvax Basic Information
10.5.2 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
10.5.3 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Market Performance
10.5.4 Walvax Business Overview
10.5.5 Walvax Recent Developments
11 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET FORECAST BY REGION
11.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast
11.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region
11.2.4 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2026-2035)
12.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2026-2035)
12.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) Forecast by Application
12.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 Key Market Segments
1.2.1 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
1.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Product Life Cycle
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2020-2025)
3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
3.8.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to 23-Valent Pneumococcal Polysaccharide Vaccine Market
5.7 ESG Ratings of Leading Companies
6 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
6.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type (2020-2025)
6.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2020-2025)
7 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Sales by Application (2020-2025)
7.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
8 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET SALES BY REGION
8.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
8.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
8.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region
8.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
8.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
8.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
8.3 North America
8.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
8.3.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
8.4.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
8.5.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
8.6.2 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
8.7.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of 23-Valent Pneumococcal Polysaccharide Vaccine by Region(2020-2025)
9.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production
9.4.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.4.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production
9.5.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production (2020-2025)
9.6.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China 23-Valent Pneumococcal Polysaccharide Vaccine Production (2020-2025)
9.7.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.7.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
10.1.3 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Sinovac
10.2.1 Sinovac Basic Information
10.2.2 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
10.2.3 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Market Performance
10.2.4 Sinovac Business Overview
10.2.5 Sinovac SWOT Analysis
10.2.6 Sinovac Recent Developments
10.3 Kangtai Bio
10.3.1 Kangtai Bio Basic Information
10.3.2 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
10.3.3 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Market Performance
10.3.4 Kangtai Bio Business Overview
10.3.5 Kangtai Bio SWOT Analysis
10.3.6 Kangtai Bio Recent Developments
10.4 CDIBP
10.4.1 CDIBP Basic Information
10.4.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
10.4.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Market Performance
10.4.4 CDIBP Business Overview
10.4.5 CDIBP Recent Developments
10.5 Walvax
10.5.1 Walvax Basic Information
10.5.2 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
10.5.3 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Market Performance
10.5.4 Walvax Business Overview
10.5.5 Walvax Recent Developments
11 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET FORECAST BY REGION
11.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast
11.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region
11.2.4 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2026-2035)
12.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2026-2035)
12.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) Forecast by Application
12.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type (M USD)
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
Table 5. 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Comparison by Region (M USD)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2025)
Table 11. Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (K MT)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type (M USD)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type (2020-2025)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) by Application
Table 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
Table 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application (2020-2025)
Table 39. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (2020-2025)
Table 44. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
Table 64. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Sinovac Basic Information
Table 69. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
Table 70. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Sinovac Business Overview
Table 72. Sinovac SWOT Analysis
Table 73. Sinovac Recent Developments
Table 74. Kangtai Bio Basic Information
Table 75. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
Table 76. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Kangtai Bio Business Overview
Table 78. Kangtai Bio SWOT Analysis
Table 79. Kangtai Bio Recent Developments
Table 80. CDIBP Basic Information
Table 81. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
Table 82. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CDIBP Business Overview
Table 84. CDIBP Recent Developments
Table 85. Walvax Basic Information
Table 86. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
Table 87. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Walvax Business Overview
Table 89. Walvax Recent Developments
Table 90. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 91. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 92. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 93. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 95. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 97. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 99. South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 101. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 102. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 103. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 104. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 105. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 106. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type (M USD)
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
Table 5. 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Comparison by Region (M USD)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2025)
Table 11. Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (K MT)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type (M USD)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type (2020-2025)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) by Application
Table 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
Table 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application (2020-2025)
Table 39. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (2020-2025)
Table 44. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
Table 64. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Sinovac Basic Information
Table 69. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
Table 70. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Sinovac Business Overview
Table 72. Sinovac SWOT Analysis
Table 73. Sinovac Recent Developments
Table 74. Kangtai Bio Basic Information
Table 75. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
Table 76. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Kangtai Bio Business Overview
Table 78. Kangtai Bio SWOT Analysis
Table 79. Kangtai Bio Recent Developments
Table 80. CDIBP Basic Information
Table 81. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
Table 82. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CDIBP Business Overview
Table 84. CDIBP Recent Developments
Table 85. Walvax Basic Information
Table 86. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
Table 87. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Walvax Business Overview
Table 89. Walvax Recent Developments
Table 90. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 91. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 92. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 93. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 95. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 97. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 99. South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 101. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 102. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 103. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 104. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 105. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 106. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD), 2025-2035
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Product Life Cycle
Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2025
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2025
Figure 18. Industry Chain Map of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market PEST Analysis
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type
Figure 27. Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2025
Figure 29. Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2020-2025)
Figure 30. Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application
Figure 33. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2025
Figure 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application (2020-2025)
Figure 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application in 2025
Figure 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (2020-2025)
Figure 40. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 43. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country in 2024
Figure 45. U.S. 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 53. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country in 2024
Figure 55. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region in 2024
Figure 68. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (K MT)
Figure 79. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 80. South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country in 2024
Figure 82. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD), 2025-2035
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Product Life Cycle
Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2025
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2025
Figure 18. Industry Chain Map of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market PEST Analysis
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type
Figure 27. Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2025
Figure 29. Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2020-2025)
Figure 30. Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application
Figure 33. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2025
Figure 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application (2020-2025)
Figure 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application in 2025
Figure 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (2020-2025)
Figure 40. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 43. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country in 2024
Figure 45. U.S. 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 53. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country in 2024
Figure 55. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region in 2024
Figure 68. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (K MT)
Figure 79. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 80. South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country in 2024
Figure 82. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China 23-Valent Pneumococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Application (2026-2035)
